The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through Thursday, May 27, 2021.
To access the conference call, follow these instructions:
Dial: (877) 881-2183 (
Conference ID: 9233368 (Nektar Therapeutics is the host)
About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco,
Vivian Wu of Nektar Therapeutics
View original content to download multimedia:http://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-first-quarter-2021-on-thursday-may-6-2021-after-close-of-us-based-financial-markets-301278444.html